TEM
Tempus AI, Inc. · Healthcare · Health Information Services
$69.36
+1.53% today · +0.12% 1W
Oct 15 close or latest
ReadoutWhy it's moving
Moving with its group (XLV +2.5%)
- TEM +1.53% on the last session vs SPY −0.09%: +1.6 pts of stock-specific move.
- The health care ETF (XLV) +2.5% (+2.6 pts vs SPY): the stock moved with its group.
- 1 analyst action in the past 10 days (1 positive, 0 negative); latest: Canaccord Genuity maintained Buy, raised target $80.00 → $95.00.
- 6 insider or congressional trades in the past 30 days.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Meta Analyst score Buy 4.1/10 (+0.54 raw)
Every firm's latest rating in the past year, each weighted by its age (a 3-month-old call counts half as much as today's), blended with the consensus of 20 analysts (+0.55, counted like 1.5 fresh ratings). 19 firms, 13 with a call in the past 3 months.
| Firm | Latest rating | Date | Weight |
|---|---|---|---|
| Canaccord Genuity | Buy | Oct 12, 2026 | 8% |
| Guggenheim | Buy | Oct 1, 2026 | 7% |
| Goldman Sachs | Neutral | Sep 21, 2026 | 7% |
| HC Wainwright & Co. | Buy | Sep 11, 2026 | 6% |
| UBS | Neutral | Sep 9, 2026 | 6% |
| Roth Capital | Neutral | Sep 8, 2026 | 6% |
| Rothschild & Co | Neutral | Sep 8, 2026 | 6% |
| Cantor Fitzgerald | Overweight | Sep 2, 2026 | 6% |
| Piper Sandler | Overweight upgrade | Sep 1, 2026 | 6% |
| Freedom Capital Markets | Hold | Aug 31, 2026 | 6% |
| BTIG | Buy | Aug 20, 2026 | 5% |
| Stifel | Hold | Aug 3, 2026 | 5% |
Buy is what the ratings average to, +0.54 on a scale from −2 (strong sell) to +2 (strong buy). 4.1/10 means better than 41% of S&P 500 stocks (503 scored, Oct 11, 2026): analysts rarely say sell, so most stocks land between +0.4 and +0.8, and the 0–10 shows where this one sits among them.
Mean target
$73.56
+6.0% upside
Median target
$75.00
+8.1% upside
Target range
35.00–100.00
low to high
Analysts
20
as of Oct 13
Price vs. targets
Low $35
Mean $74
High $100
Now $69.36
Consensus
Strong buy 2Buy 8Hold 9Sell 1Strong sell 0
Rating and target changes
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| Oct 12, 2026 | Canaccord Genuity | Raised target | Buy | $80.00 → $95.00 |
| Oct 1, 2026 | Guggenheim | Raised target | Buy | $65.00 → $92.00 |
| Sep 21, 2026 | Goldman Sachs | Initiated | Neutral | $75.00 |
| Sep 11, 2026 | HC Wainwright & Co. | Raised target | Buy | $56.00 → $66.00 |
| Sep 9, 2026 | UBS | Initiated | Neutral | $70.00 |
| Sep 8, 2026 | Roth Capital | Initiated | Neutral | $67.00 |
| Sep 8, 2026 | Rothschild & Co | Initiated | Neutral | $67.00 |
| Sep 2, 2026 | Cantor Fitzgerald | Initiated | Overweight | $80.00 |
| Sep 1, 2026 | Piper Sandler | Upgrade | Neutral → Overweight | $56.00 → $76.00 |
| Aug 31, 2026 | Freedom Capital Markets | Raised target | Hold | $51.00 → $73.00 |
| Aug 20, 2026 | BTIG | Raised target | Buy | $70.00 → $80.00 |
| Aug 4, 2026 | Piper Sandler | Lowered target | Neutral | $58.00 → $56.00 |
| Aug 3, 2026 | Stifel | Lowered target | Hold | $60.00 → $50.00 |
| Aug 3, 2026 | HC Wainwright & Co. | Lowered target | Buy | $64.00 → $56.00 |
| Aug 3, 2026 | BTIG | Lowered target | Buy | $80.00 → $70.00 |
| Jul 31, 2026 | Needham | Reiterated | Buy | $75.00 |
| Jul 20, 2026 | Needham | Reiterated | Buy | $75.00 |
| Jul 16, 2026 | Guggenheim | Raised target | Buy | $60.00 → $65.00 |
| Jul 1, 2026 | Freedom Capital Markets | Initiated | Hold | $59.00 |
| Jun 1, 2026 | BTIG | Reiterated | Buy | $80.00 |
| Jun 1, 2026 | Needham | Reiterated | Buy | $75.00 |
| May 11, 2026 | HC Wainwright & Co. | Lowered target | Buy | $95.00 → $64.00 |
| May 8, 2026 | BTIG | Lowered target | Buy | $90.00 → $80.00 |
| May 6, 2026 | TD Cowen | Raised target | Buy | $65.00 → $68.00 |
| Apr 13, 2026 | Jefferies | Initiated | Underperform | $35.00 |
| Mar 30, 2026 | Guggenheim | Lowered target | Buy | $95.00 → $60.00 |
| Mar 11, 2026 | Needham | Reiterated | Buy | $75.00 |
| Mar 9, 2026 | HC Wainwright & Co. | Raised target | Buy | $89.00 → $95.00 |
| Mar 3, 2026 | Morgan Stanley | Lowered target | Overweight | $85.00 → $70.00 |
| Feb 25, 2026 | BTIG | Lowered target | Buy | $105.00 → $90.00 |
| Feb 25, 2026 | Needham | Lowered target | Buy | $100.00 → $75.00 |
| Feb 25, 2026 | JP Morgan | Lowered target | Neutral | $80.00 → $60.00 |
| Feb 19, 2026 | Mizuho | Initiated | Outperform | $100.00 |
| Feb 17, 2026 | Baird | Initiated | Outperform | $59.00 |
| Dec 22, 2025 | Canaccord Genuity | Lowered target | Buy | $95.00 → $80.00 |
| Dec 15, 2025 | JP Morgan | Lowered target | Neutral | $85.00 → $80.00 |
| Dec 2, 2025 | Morgan Stanley | Raised target | Overweight | $80.00 → $85.00 |
| Nov 25, 2025 | BTIG | Raised target | Buy | $96.00 → $105.00 |
| Nov 11, 2025 | Morgan Stanley | Raised target | Overweight | $68.00 → $80.00 |
| Nov 11, 2025 | Piper Sandler | Lowered target | Neutral | $105.00 → $80.00 |
Source: Yahoo Finance analyst data, collected daily.